{"DataElement":{"publicId":"3232952","version":"1","preferredName":"Iodine I 131 Total Administered Preparation Technique Name","preferredDefinition":"A radioactive isotope of iodine with an atomic mass of 131, a half life of eight days, and potential antineoplastic activity. Selectively accumulating in the thyroid gland, iodine I 131 emits beta and gamma particles, thereby killing thyroid cells and decreasing thyroid hormone production._Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition._Given._The act or process of making something ready; also a medication made ready for administration; also an anatomic or pathologic specimen made ready and preserved for study._A practiced and regimented skill or series of actions._The words or language units by which a thing is known.","longName":"3232903v1.0:3232947v1.0","context":"NCIP","contextVersion":"1","DataElementConcept":{"publicId":"3232903","version":"1","preferredName":"Iodine I 131 Total Administered","preferredDefinition":"A radioactive isotope of iodine with an atomic mass of 131, a half life of eight days, and potential antineoplastic activity. Selectively accumulating in the thyroid gland, iodine I 131 emits beta and gamma particles, thereby killing thyroid cells and decreasing thyroid hormone production._Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition._Given.","longName":"3232893v1.0:2479707v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3232893","version":"1","preferredName":"Iodine I 131","preferredDefinition":"A radioactive isotope of iodine with an atomic mass of 131, a half life of eight days, and potential antineoplastic activity. Selectively accumulating in the thyroid gland, iodine I 131 emits beta and gamma particles, thereby killing thyroid cells and decreasing thyroid hormone production.","longName":"C1639","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Iodine I-131","conceptCode":"C1639","definition":"A radioactive isotope of iodine with an atomic mass of 131, a half life of eight days, and potential antineoplastic activity. Selectively accumulating in the thyroid gland, iodine I 131 emits beta and gamma particles, thereby killing thyroid cells and decreasing thyroid hormone production.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2612AD4-B703-40AE-E040-BB89AD4303EC","latestVersionIndicator":"Yes","beginDate":"2011-05-03","endDate":null,"createdBy":"WHITES","dateCreated":"2011-05-03","modifiedBy":"ONEDATA","dateModified":"2011-05-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2479707","version":"1","preferredName":"Total Administered","preferredDefinition":"Pertaining to an entirety or whole, also constituting the full quantity or extent; complete.:Given.","longName":"C25304:C25382","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Total","conceptCode":"C25304","definition":"Pertaining to an entirety or whole, also constituting the full quantity or extent; complete; derived by addition.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Administered","conceptCode":"C25382","definition":"The act of having given something (e.g., a medication or test).","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"126DA759-029B-7141-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-04-27","endDate":null,"createdBy":"PWEST","dateCreated":"2006-04-27","modifiedBy":"ONEDATA","dateModified":"2006-04-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2617475-B273-4147-E040-BB89AD4328B1","latestVersionIndicator":"Yes","beginDate":"2011-05-03","endDate":null,"createdBy":"WHITES","dateCreated":"2011-05-03","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of T. Lichtenberg 4/2011","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3232947","version":"1","preferredName":"Iodine I 131 Preparation Technique Name","preferredDefinition":"A radioactive isotope of iodine with an atomic mass of 131, a half life of eight days, and potential antineoplastic activity. Selectively accumulating in the thyroid gland, iodine I 131 emits beta and gamma particles, thereby killing thyroid cells and decreasing thyroid hormone production._The act or process of making something ready; also a medication made ready for administration; also an anatomic or pathologic specimen made ready and preserved for study._A practiced and regimented skill or series of actions._The words or language units by which a thing is known.","longName":"3232947v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"40","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Patient did not receive I-131 treatment","valueDescription":"Negation Iodine I 131 Therapeutic Procedure","ValueMeaning":{"publicId":"3232948","version":"1","preferredName":"Negation Iodine I 131 Therapeutic Procedure","longName":"3232948","preferredDefinition":"An operation in which a term denies or inverts the meaning of another term or construction.: A radioactive isotope of iodine with an atomic mass of 131, a half life of eight days, and potential antineoplastic activity. Selectively accumulating in the thyroid gland, iodine I 131 emits beta and gamma particles, thereby killing thyroid cells and decreasing thyroid hormone production.: An action or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Negation","conceptCode":"C25594","definition":"An operation in which a term denies or inverts the meaning of another term or construction.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Iodine I-131","conceptCode":"C1639","definition":"A radioactive isotope of iodine with an atomic mass of 131, a half life of eight days, and potential antineoplastic activity. Selectively accumulating in the thyroid gland, iodine I 131 emits beta and gamma particles, thereby killing thyroid cells and decreasing thyroid hormone production.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Therapeutic Procedure","conceptCode":"C49236","definition":"An action or administration of therapeutic agents to produce an effect that is intended to alter or stop a pathologic process.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2616CED-2DAC-91B8-E040-BB89AD435184","latestVersionIndicator":"Yes","beginDate":"2011-05-03","endDate":null,"createdBy":"WHITES","dateCreated":"2011-05-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A2616CED-2DC5-91B8-E040-BB89AD435184","beginDate":"2011-05-03","endDate":null,"createdBy":"WHITES","dateCreated":"2011-05-03","modifiedBy":"ONEDATA","dateModified":"2011-05-03","deletedIndicator":"No"},{"value":"Thyroxine withdrawal","valueDescription":"Withdraw Thyroxine","ValueMeaning":{"publicId":"3232949","version":"1","preferredName":"Withdraw Thyroxine","longName":"3232949","preferredDefinition":"To cease active participation in; remove from active use.: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Withdraw","conceptCode":"C38061","definition":"To cease active participation in; remove from active use.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Thyroxine","conceptCode":"C2302","definition":"A hormone synthesized and secreted by the thyroid gland containing four iodine atoms and is converted to triiodothyronine (T3) in the body, influencing metabolism and organ function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2616CED-2DD2-91B8-E040-BB89AD435184","latestVersionIndicator":"Yes","beginDate":"2011-05-03","endDate":null,"createdBy":"WHITES","dateCreated":"2011-05-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A2616CED-2DEB-91B8-E040-BB89AD435184","beginDate":"2011-05-03","endDate":null,"createdBy":"WHITES","dateCreated":"2011-05-03","modifiedBy":"ONEDATA","dateModified":"2011-05-03","deletedIndicator":"No"},{"value":"rhTSH","valueDescription":"Recombinant Thyroid-Stimulating Hormone","ValueMeaning":{"publicId":"3232951","version":"1","preferredName":"Recombinant Thyroid-Stimulating Hormone","longName":"3232951","preferredDefinition":"A peptide hormone secreted by the anterior pituitary. It promotes the growth of the thyroid gland and stimulates the synthesis of thyroid hormones and the release of thyroxine by the thyroid gland.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Recombinant Thyroid-Stimulating Hormone","conceptCode":"C887","definition":"A recombinant form of the heterodimeric human anterior pituitary glycoprotein thyroid-stimulating hormone (TSH) with potential use in hormone replacement therapy. Recombinant TSH binds to TSH receptors on thyroid epithelial cells and stimulates TSH-dependent signaling pathways. This stimulates iodine uptake and organification, and induces synthesis and secretion of thyroglobulin (Tg), triiodothyronine (T3), and thyroxine (T4).","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2616CED-2DF8-91B8-E040-BB89AD435184","latestVersionIndicator":"Yes","beginDate":"2011-05-03","endDate":null,"createdBy":"WHITES","dateCreated":"2011-05-03","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"A2616CED-2E11-91B8-E040-BB89AD435184","beginDate":"2011-05-03","endDate":null,"createdBy":"WHITES","dateCreated":"2011-05-03","modifiedBy":"ONEDATA","dateModified":"2011-05-03","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008538","version":"1","preferredName":"Therapies","preferredDefinition":"actions or administration of therapeutic agents to produce an effect that is intended to alter the course of a pathologic process (NCI).","longName":"TX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B214D04D-9F05-1CA5-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-18","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-18","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3232946","version":"1","preferredName":"Iodine I 131 Preparation Technique Name","preferredDefinition":"A radioactive isotope of iodine with an atomic mass of 131, a half life of eight days, and potential antineoplastic activity. Selectively accumulating in the thyroid gland, iodine I 131 emits beta and gamma particles, thereby killing thyroid cells and decreasing thyroid hormone production.:The act or process of making something ready; also a medication made ready for administration; also an anatomic or pathologic specimen made ready and preserved for study.:A practiced and regimented skill or series of actions.:The words or language units by which a thing is known.","longName":"C1639:C25625:C16847:C42614","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Iodine I-131","conceptCode":"C1639","definition":"A radioactive isotope of iodine with an atomic mass of 131, a half life of eight days, and potential antineoplastic activity. Selectively accumulating in the thyroid gland, iodine I 131 emits beta and gamma particles, thereby killing thyroid cells and decreasing thyroid hormone production.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Preparation","conceptCode":"C25625","definition":"The act or process of making something ready.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Technique","conceptCode":"C16847","definition":"A practiced and regimented skill or series of actions.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Name","conceptCode":"C42614","definition":"The words or language units by which a thing is known.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2616CED-2D81-91B8-E040-BB89AD435184","latestVersionIndicator":"Yes","beginDate":"2011-05-03","endDate":null,"createdBy":"WHITES","dateCreated":"2011-05-03","modifiedBy":"ONEDATA","dateModified":"2011-05-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2616CED-2D92-91B8-E040-BB89AD435184","latestVersionIndicator":"Yes","beginDate":"2011-05-03","endDate":null,"createdBy":"WHITES","dateCreated":"2011-05-03","modifiedBy":"WHITES","dateModified":"2011-05-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2756809","version":"1","longName":"TCGA (The Cancer Genome Atlas)","context":"NCIP","ClassificationSchemeItems":[{"publicId":"6044923","version":"1","longName":"Active CDEs as of March 2017","context":"NCIP"}]},{"publicId":"3787498","version":"1","longName":"TCGA 2.6 by Disease","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3787521","version":"1","longName":"THCA","context":"NCIP"}]}],"AlternateNames":[{"name":"i_131_total_administered_preparation_technique","type":"TCGA_XML_Name","context":"NCIP"}],"ReferenceDocuments":[{"name":"I-131 Treatment: Method of pr","type":"Preferred Question Text","description":"I-131 Treatment: Method of preparation","url":null,"context":"NCIP"}],"origin":"TCGA:The Cancer Genome Atlas","workflowStatus":"RELEASED","registrationStatus":"Application","id":"A2616CED-2E2A-91B8-E040-BB89AD435184","latestVersionIndicator":"Yes","beginDate":"2011-05-03","endDate":null,"createdBy":"WHITES","dateCreated":"2011-05-03","modifiedBy":"TSESU","dateModified":"2018-07-13","changeDescription":"Curated for The Cancer Genome Atlas (TCGA) by request of T. Lichtenberg 4/2011","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}